查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974345

生物活性成分市場分析及預測（至2035年）：類型、產品、技術、應用、劑型、最終用戶、功能、安裝類型、解決方案

Bioactive Ingredients Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Form, End User, Functionality, Installation Type, Solutions
出版日期: | 出版商: Global Insight Services | 英文 387 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

生物活性成分市場預計將從2024年的385億美元成長到2034年的653億美元，複合年成長率約為5.4%。生物活性成分市場涵蓋從植物和海洋生物等天然資源中提取的化合物，這些化合物除了提供基本營養外，還具有其他健康益處。這些成分具有抗氧化、抗發炎和增強免疫力等特性，使其成為機能性食品、營養保健品和藥品的重要組成部分。消費者健康意識的不斷提高，以及提取技術的進步，正在推動市場成長，並促進個人化營養和預防醫學領域的創新。

全球生物活性成分市場正處於複雜的環境之中，受到關稅、地緣政治緊張局勢和不斷變化的供應鏈動態的影響。日本和韓國正在動態國內產能，以在關稅不確定性和地緣政治風險的背景下降低進口依賴。由於貿易摩擦以及對國內技術創新的重視，中國正加速向生物活性化合物自給自足的戰略轉型。台灣強大的生技產業依然重要，但也面臨地緣政治的脆弱性。在健康和保健產品需求不斷成長的推動下，母市場正經歷強勁成長。到2035年，市場發展將取決於區域合作和供應鏈的韌性。同時，中東衝突可能會擾亂全球供應鏈，影響能源價格，並對整個生物活性成分產業的生產成本產生連鎖反應。

市場區隔
類型 益生菌、益生元、胺基酸、胜肽、抗氧化劑、維生素、礦物質、類胡蘿蔔素、植物化學物質
產品 營養補充品、機能性食品、機能飲料、個人保健產品、動物營養產品、藥品
科技 微膠囊化、奈米膠囊化、發酵、萃取、噴霧乾燥、冷凍乾燥、乳化
目的 食品飲料、藥品、化妝品、農業
形式 液體、粉末、凝膠、膠囊、錠劑、顆粒劑
最終用戶 食品工業、製藥工業、化妝品工業、飼料工業
功能 免疫健康、骨骼健康、心臟健康、消化健康、皮膚健康、體重管理、認知健康
安裝類型 本機部署、雲端部署
解決方案 定製配方、標準化產品、自有品牌。

受消費者對健康產品需求不斷成長的推動，生物活性成分市場正經歷強勁成長。營養補充品領域引領潮流，其中維生素和礦物質是維持整體健康所必需的。益生菌和益生元在消化健康方面發揮著至關重要的作用，也推動了它們的普及。食品飲料產業緊隨其後，反映出人們日益成長的健康飲食習慣。雖然植物來源的生物活性成分因其天然特性而備受關注，但合成生物活性成分憑藉其穩定性和高效性仍然佔著重要地位。

受抗衰老和護膚產品需求的推動，化妝品和個人護理行業也不斷擴張。膠原蛋白和胜肽因其增強皮膚彈性的功效而成為人們的首選。研發投入的增加推動了創新，並促使新型生物活性化合物的問世。此外，消費者對個人化營養解決方案的需求也不斷成長，以最佳化健康益處並提升消費者滿意度。

生物活性成分市場正展現出強勁的成長勢頭，這主要得益於消費者偏好的不斷變化和創新產品的持續推出。定價策略日趨激烈，反映了行業的動態特性和新成分的不斷湧現。各公司正不斷拓展產品系列，以滿足消費者對機能性食品和營養保健品日益成長的需求。此外，對永續性和潔淨標示產品的關注也進一步強化了這一趨勢，這些因素正成為影響各細分市場消費者購買決策的關鍵因素。

生物活性成分市場競爭異常激烈，主要企業透過策略聯盟和收購爭奪市場主導地位。法規結構，尤其是在北美和歐洲，在確保產品安全性和有效性以及塑造市場動態發揮著至關重要的作用。這些法規雖然嚴格，但也透過設定高標準的行業規範促進了創新。亞太地區的新興市場也正在蓬勃發展，為企業擴張提供了廣闊的機會。該行業既有成熟的企業，也有充滿活力的Start-Ups，它們共同推動著行業的強勁成長。

主要趨勢和促進因素：

在消費者對健康產品需求不斷成長的推動下，生物活性成分市場正經歷強勁成長。這一趨勢在營養補充劑和機能性食品領域尤為明顯，消費者越來越傾向於尋求能夠提供除基本營養攝取之外的健康益處的產品。全球老化和日益增強的健康意識是主要驅動力，促使人們普遍尋求透過飲食來管理自身健康並延長壽命。

萃取和配方過程的技術創新正在推動更有效的生物活性成分的開發。這些創新提高了生物利用度和功效，從而增強了產品的有效性。此外，受消費者對潔淨標示產品和永續性的偏好驅動，植物來源和天然成分的需求日益成長。這種轉變刺激了製造商加大研發投入，以發現新的生物活性化合物來源。

監管支持在市場擴張中也發揮著至關重要的作用。這是因為世界各國政府都認知到生物活性成分的潛在健康益處，並制定了更有利的法規和標準。這種法規環境促進了創新，也使新進入者更容易進入市場。此外，主要產業參與者之間的策略聯盟和夥伴關係促進了知識共用，加速了產品開發，並進一步推動了市場成長。

壓制與挑戰：

目前，生物活性成分市場面臨許多重大限制與挑戰。其中一個突出的挑戰是生物活性成分核准和使用監管框架的嚴格性，這可能導致產品上市延遲和合規成本增加。此外，研發新型生物活性化合物的高成本也阻礙了中小企業的發展，限制了創新。消費者對生物活性成分功效和安全性的質疑也構成障礙，需要廣泛的行銷和宣傳活動。此外，市場還面臨供應鏈中斷的問題，尤其是在從不同地區採購原料方面，這可能導致價格波動。最後，如何在不影響產品品質和穩定性的前提下將生物活性成分整合到現有產品配方中，是一項技術挑戰，需要先進的專業知識和投資。所有這些因素共同構成了生物活性成分市場成長和擴張的重大挑戰。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 益生菌
    • 益生元
    • 胺基酸
    • 胜肽
    • 抗氧化劑
    • 維他命
    • 礦物
    • 類胡蘿蔔素
    • 植物化學物質
  • 市場規模及預測：依產品分類
    • 營養補充品
    • 機能性食品
    • 機能飲料
    • 個人保健產品
    • 動物營養
    • 製藥
  • 市場規模及預測：依技術分類
    • 微膠囊化
    • 奈米封裝
    • 發酵
    • 萃取
    • 噴霧乾燥
    • 冷凍乾燥
    • 乳化
  • 市場規模及預測：依應用領域分類
    • 食品/飲料
    • 製藥
    • 化妝品
    • 農業
  • 市場規模及預測：依類型
    • 液體
    • 粉末
    • 凝膠
    • 膠囊
    • 藥片
    • 顆粒
  • 市場規模及預測：依最終用戶分類
    • 食品工業
    • 製藥業
    • 化妝品產業
    • 飼料業
  • 市場規模及預測：依功能分類
    • 免疫健康
    • 骨骼健康
    • 心臟健康
    • 消化系統健康
    • 皮膚健康
    • 體重管理
    • 認知健康
  • 市場規模及預測：依安裝類型分類
    • 現場
    • 基於雲端的
  • 市場規模及預測：按解決方案分類
    • 定製配方
    • 標準化產品
    • 自有品牌

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Sabinsa Corporation
  • Glanbia Nutritionals
  • Nutraceutical International Corporation
  • Frutarom Industries
  • Archer Daniels Midland Company
  • BASF SE
  • Cargill Incorporated
  • Koninklijke DSM NV
  • Ingredion Incorporated
  • Kemin Industries
  • Chr. Hansen Holding A/S
  • FMC Corporation
  • Roquette Freres
  • Lonza Group
  • EI du Pont de Nemours and Company
  • DSM Nutritional Products
  • Kerry Group
  • Evonik Industries AG
  • Novozymes A/S
  • Tate & Lyle PLC

第9章 關於我們

簡介目錄
Product Code: GIS10503

Bioactive Ingredients Market is anticipated to expand from $38.5 billion in 2024 to $65.3 billion by 2034, growing at a CAGR of approximately 5.4%. The Bioactive Ingredients Market encompasses compounds extracted from natural sources, including plants and marine organisms, that provide health benefits beyond basic nutrition. These ingredients are integral to functional foods, nutraceuticals, and pharmaceuticals, offering properties such as antioxidant, anti-inflammatory, and immune-boosting effects. Rising consumer awareness of health and wellness, coupled with advancements in extraction technologies, drives market growth, fostering innovations in personalized nutrition and preventive healthcare.

The global bioactive ingredients market is navigating a complex landscape of tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are enhancing domestic production capabilities to mitigate reliance on imports, spurred by tariff uncertainties and geopolitical risks. China's strategic pivot towards self-sufficiency in bioactive compounds is accelerating, driven by trade tensions and a focus on indigenous innovation. Taiwan's robust biotech sector remains pivotal, yet it faces geopolitical vulnerabilities. The parent market is experiencing robust growth, propelled by rising demand for health and wellness products. By 2035, market evolution will hinge on regional collaborations and supply chain resilience. Concurrently, Middle East conflicts could disrupt global supply chains, influencing energy prices and impacting production costs across the bioactive ingredients sector.

Market Segmentation
TypeProbiotics, Prebiotics, Amino Acids, Peptides, Antioxidants, Vitamins, Minerals, Carotenoids, Phytochemicals
ProductDietary Supplements, Functional Foods, Functional Beverages, Personal Care Products, Animal Nutrition, Pharmaceuticals
TechnologyMicroencapsulation, Nanoencapsulation, Fermentation, Extraction, Spray Drying, Freeze Drying, Emulsification
ApplicationFood & Beverages, Pharmaceuticals, Cosmetics, Agriculture
FormLiquid, Powder, Gel, Capsule, Tablet, Granules
End UserFood Industry, Pharmaceutical Industry, Cosmetic Industry, Animal Feed Industry
FunctionalityImmune Health, Bone Health, Heart Health, Digestive Health, Skin Health, Weight Management, Cognitive Health
Installation TypeOn-premise, Cloud-based
SolutionsCustomized Formulations, Standardized Products, Private Labeling

The Bioactive Ingredients Market is experiencing robust growth, propelled by increasing consumer demand for health-enhancing products. The dietary supplements segment leads in performance, with vitamins and minerals being essential for overall well-being. Probiotics and prebiotics play a crucial role in digestive health, driving their popularity. The functional food and beverages segment follows closely, reflecting the rising trend of health-conscious eating habits. Plant-based bioactives are gaining traction due to their natural appeal, while synthetic bioactives remain relevant for their consistency and potency.

The cosmetics and personal care segment is also expanding, driven by the demand for anti-aging and skin health products. Collagen and peptides are emerging as preferred choices for their efficacy in promoting skin elasticity. Growing investments in research and development are fostering innovation, leading to the introduction of novel bioactive compounds. The demand for personalized nutrition solutions is rising, optimizing health outcomes and enhancing consumer satisfaction.

The bioactive ingredients market is witnessing significant momentum, driven by evolving consumer preferences and innovative product launches. Pricing strategies are increasingly competitive, reflecting the industry's dynamic nature and the introduction of novel ingredients. Companies are continuously expanding their product portfolios to cater to the growing demand for functional foods and nutraceuticals. This trend is further accentuated by a focus on sustainability and clean label products, which are becoming pivotal in influencing purchasing decisions across various demographics.

Competition in the bioactive ingredients market is intense, with key players vying for market dominance through strategic alliances and acquisitions. Regulatory frameworks, particularly in North America and Europe, play a crucial role in shaping market dynamics, ensuring product safety and efficacy. These regulations, while stringent, foster innovation by setting high industry standards. Emerging markets in Asia-Pacific are also gaining traction, presenting lucrative opportunities for expansion. The landscape is characterized by a blend of established companies and agile startups, each contributing to the sector's robust growth trajectory.

Geographical Overview:

The bioactive ingredients market is witnessing substantial growth across diverse regions, each exhibiting unique characteristics. North America remains at the forefront, propelled by heightened consumer awareness about health and wellness. This surge is further supported by advancements in biotechnology and significant investments in research and development of novel bioactive compounds.

Europe follows closely, with a strong emphasis on sustainable and natural ingredient sourcing, driven by stringent regulatory frameworks. This has led to a robust demand for bioactive ingredients in functional foods and nutraceuticals. In Asia Pacific, the market is rapidly expanding, fueled by rising disposable incomes and increasing health consciousness among consumers.

The region's rich biodiversity also provides a fertile ground for the development of innovative bioactive products. Latin America and the Middle East & Africa are emerging as promising growth pockets. Brazil and South Africa, in particular, are capitalizing on their abundant natural resources to develop bioactive ingredients, catering to both domestic and international markets.

Recent Developments:

The bioactive ingredients market is witnessing dynamic changes as key players engage in strategic maneuvers. In a notable development, BASF announced a partnership with a leading biotechnology firm to enhance the production of sustainable bioactive ingredients, aiming to meet the increasing consumer demand for natural products.

In a move to expand its market presence, DSM acquired a prominent bioactive ingredient company, which is expected to bolster its product portfolio and strengthen its position in the global market. This acquisition is seen as a strategic step to leverage synergies and enhance innovation capabilities.

Meanwhile, Archer Daniels Midland (ADM) launched a new line of bioactive ingredients tailored for the nutraceutical sector, highlighting the growing trend towards health-focused products. This launch is part of ADM's broader strategy to cater to the evolving consumer preferences for functional foods.

On the regulatory front, the European Union introduced new guidelines for bioactive ingredient labeling, aimed at ensuring transparency and consumer safety. These guidelines are expected to impact market dynamics by influencing product development and marketing strategies.

Lastly, the supply chain for bioactive ingredients is undergoing transformation, as companies like Cargill invest in advanced logistics solutions to optimize distribution channels. This move is anticipated to enhance supply chain efficiency and reduce operational costs, thereby providing a competitive edge in the market.

Key Trends and Drivers:

The bioactive ingredients market is experiencing robust growth, fueled by the rising consumer demand for health-enhancing products. This trend is particularly prominent in the nutraceutical and functional food sectors, where consumers are increasingly seeking products that offer health benefits beyond basic nutrition. The aging global population and growing health consciousness are significant drivers, as individuals seek to manage health conditions and improve longevity through diet.

Technological advancements in extraction and formulation processes are enabling the development of more effective bioactive ingredients. These innovations are allowing for higher bioavailability and potency, enhancing the efficacy of products. Furthermore, there is a growing trend towards plant-based and natural ingredients, driven by consumer preferences for clean-label products and sustainability. This shift is encouraging manufacturers to invest in research and development to discover new sources of bioactive compounds.

Regulatory support is also playing a crucial role in market expansion. Governments worldwide are recognizing the potential health benefits of bioactive ingredients, leading to more favorable regulations and standards. This regulatory environment is fostering innovation and facilitating market entry for new players. Additionally, strategic collaborations and partnerships among key industry players are promoting knowledge sharing and accelerating product development, further propelling market growth.

Restraints and Challenges:

The bioactive ingredients market is currently navigating several significant restraints and challenges. One notable challenge is the stringent regulatory framework governing the approval and use of bioactive ingredients, which can delay product launches and increase compliance costs. Additionally, the high cost of research and development in discovering new bioactive compounds acts as a barrier for smaller companies, limiting innovation. Consumer skepticism about the efficacy and safety of bioactive ingredients also poses a hurdle, necessitating extensive marketing and educational efforts. Furthermore, the market faces supply chain disruptions, particularly in sourcing raw materials from diverse geographical locations, which can lead to price volatility. Lastly, the complexity of integrating bioactive ingredients into existing product formulations without compromising quality or stability is a technical challenge that requires significant expertise and investment. These factors collectively pose substantial challenges to the growth and expansion of the bioactive ingredients market.

Key Companies:

Sabinsa Corporation, Glanbia Nutritionals, Nutraceutical International Corporation, Frutarom Industries, Archer Daniels Midland Company, BASF SE, Cargill Incorporated, Koninklijke DSM N. V., Ingredion Incorporated, Kemin Industries, Chr. Hansen Holding A/S, FMC Corporation, Roquette Freres, Lonza Group, E. I. du Pont de Nemours and Company, DSM Nutritional Products, Kerry Group, Evonik Industries AG, Novozymes A/S, Tate & Lyle PLC

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by Form
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Installation Type
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Probiotics
    • 4.1.2 Prebiotics
    • 4.1.3 Amino Acids
    • 4.1.4 Peptides
    • 4.1.5 Antioxidants
    • 4.1.6 Vitamins
    • 4.1.7 Minerals
    • 4.1.8 Carotenoids
    • 4.1.9 Phytochemicals
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Dietary Supplements
    • 4.2.2 Functional Foods
    • 4.2.3 Functional Beverages
    • 4.2.4 Personal Care Products
    • 4.2.5 Animal Nutrition
    • 4.2.6 Pharmaceuticals
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Microencapsulation
    • 4.3.2 Nanoencapsulation
    • 4.3.3 Fermentation
    • 4.3.4 Extraction
    • 4.3.5 Spray Drying
    • 4.3.6 Freeze Drying
    • 4.3.7 Emulsification
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Food & Beverages
    • 4.4.2 Pharmaceuticals
    • 4.4.3 Cosmetics
    • 4.4.4 Agriculture
  • 4.5 Market Size & Forecast by Form (2020-2035)
    • 4.5.1 Liquid
    • 4.5.2 Powder
    • 4.5.3 Gel
    • 4.5.4 Capsule
    • 4.5.5 Tablet
    • 4.5.6 Granules
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Food Industry
    • 4.6.2 Pharmaceutical Industry
    • 4.6.3 Cosmetic Industry
    • 4.6.4 Animal Feed Industry
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Immune Health
    • 4.7.2 Bone Health
    • 4.7.3 Heart Health
    • 4.7.4 Digestive Health
    • 4.7.5 Skin Health
    • 4.7.6 Weight Management
    • 4.7.7 Cognitive Health
  • 4.8 Market Size & Forecast by Installation Type (2020-2035)
    • 4.8.1 On-premise
    • 4.8.2 Cloud-based
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Customized Formulations
    • 4.9.2 Standardized Products
    • 4.9.3 Private Labeling

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 Form
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
      • 5.2.1.8 Installation Type
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 Form
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
      • 5.2.2.8 Installation Type
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 Form
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
      • 5.2.3.8 Installation Type
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 Form
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
      • 5.3.1.8 Installation Type
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 Form
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
      • 5.3.2.8 Installation Type
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 Form
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
      • 5.3.3.8 Installation Type
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 Form
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
      • 5.4.1.8 Installation Type
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 Form
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
      • 5.4.2.8 Installation Type
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 Form
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
      • 5.4.3.8 Installation Type
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 Form
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
      • 5.4.4.8 Installation Type
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 Form
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
      • 5.4.5.8 Installation Type
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 Form
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
      • 5.4.6.8 Installation Type
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 Form
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
      • 5.4.7.8 Installation Type
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 Form
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
      • 5.5.1.8 Installation Type
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 Form
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
      • 5.5.2.8 Installation Type
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 Form
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
      • 5.5.3.8 Installation Type
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 Form
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
      • 5.5.4.8 Installation Type
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 Form
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Installation Type
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 Form
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
      • 5.5.6.8 Installation Type
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 Form
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
      • 5.6.1.8 Installation Type
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 Form
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
      • 5.6.2.8 Installation Type
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 Form
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
      • 5.6.3.8 Installation Type
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 Form
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
      • 5.6.4.8 Installation Type
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 Form
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality
      • 5.6.5.8 Installation Type
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Sabinsa Corporation
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Glanbia Nutritionals
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Nutraceutical International Corporation
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Frutarom Industries
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Archer Daniels Midland Company
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 BASF SE
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Cargill Incorporated
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Koninklijke DSM N. V.
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Ingredion Incorporated
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Kemin Industries
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Chr. Hansen Holding A/S
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 FMC Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Roquette Freres
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lonza Group
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 E. I. du Pont de Nemours and Company
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 DSM Nutritional Products
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Kerry Group
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Evonik Industries AG
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Novozymes A/S
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Tate & Lyle PLC
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us